28
M.-J.R.P. Queiroz et al. / Journal of Photochemistry and Photobiology A: Chemistry 255 (2013) 27–35
NH2
N
CO2Me
S
2a R3 = H, 90%
2b R3 = OMe, 90%
R3
HN
HN
O
2c R3 = CN, 80%
O
C
N
R3 = H, OMe or CN
R3
NH2
N
CH2Cl2/THF
rt, 16h
CO2Me
S
NH2
N
R2
CO2Me
R1
S
1a R1 =NH2, R2 =H
1b R2 =NH2, R1 = H
NH
3a R3 = H, 75%
3b R3 = OMe, 70%
3c R3 = CN, 75%
HN
O
R3
Scheme 1. Synthesis of 1,3-diarylureas 2 and 3 derivatives of thieno[3,2-b]pyridines by reaction of anilines with arylisocyanates.
on a Bruker Avance III at 400 and 100.6 MHz or on a Varian Unity
Plus at 300 and 75.4 MHz, respectively. Heteronuclear correlations,
1H–13C, HMQC or HSQC were performed to attribute some signals.
HRMS data were recorded using a method of direct injection by
ESI-TOF by the mass spectrometry service of the University of Vigo,
Spain.
(Macherey-Nagel) of 0.2 mm, with UV254 fluorescence indicator.
3.83 (s, 3H, OMe), 6.87 (2H, d, J = 9.2 Hz, 3ꢀꢀ and 5ꢀꢀ-H), 6.93 (2H,
br s, NH2), 7.36 (2H, d, J = 9.2 Hz, 2ꢀꢀ and 6ꢀꢀ-H), 7.38–7.50 (3H, m,
ArH), 7.89 (1H, br s, 2ꢀ-H), 8.55 (1H, br s, NH), 8.61 (1H, d, J = 2.0 Hz,
7-H), 8.73 (1H, broad s, NH), 8.92 (1H, d, J = 2.0 Hz, 5-H) ppm. 13C
NMR (100.6 MHz, DMSO-d6): ı 51.6 (OMe), 55.2 (OMe), 97.4 (C),
114.0 (3ꢀꢀ and 5ꢀꢀ-CH), 116.9 (2ꢀ-CH), 118.3 (CH), 120.2 (2ꢀꢀ and
6ꢀꢀ-CH), 120.8 (CH), 129.3 (7-CH), 129.7 (CH), 132.6 (C), 133.9 (C),
135.2 (C), 137.3 (C), 140.7 (C), 145.4 (C), 145.5 (5-CH), 147.9 (C),
152.8 (C O), 154.6 (C), 164.6 (C O) ppm. HRMS (ESI-TOF) Calcd.
for C23H21N4O4S [M+H]+ 449.1284; found 449.1284.
2.1.2. General procedure for the synthesis of 1,3-diarylureas
(Scheme 1)
2.1.2.3. Methyl
3-amino-6-{3-[3-(4-cyanophenyl)ureido]phenyl}
Compounds 1a–b [6] and different arylisocyanates (1 equiv.)
in 6 mL CH2Cl2:THF (1:1) were left stirring at room temperature
for 16 h. If a precipitate did not come out after this time, hex-
ane (3–5 mL) was added to the mixture to precipitate the product.
This was filtered under vacuum to give the corresponding 1,3-
diarylureas.
thieno[3,2-b]pyridine-2-carboxylate (2c). From compound 1a
(100 mg, 0.330 mmol) and 4-cyanophenylisocyanate (50.0 mg)
compound 2c was isolated as a yellow solid (120 mg, 80%), m.p.
264–265 ◦C. 1H NMR (300 MHz, DMSO-d6): ı 3.83 (3H, s, OMe),
6.94 (2H, br s, NH2), 7.45–7.47 (2H, m, ArH), 7.49–7.54 (1H, m,
ArH), 7.65 (2H, d, J = 9.0 Hz, 2ꢀꢀ and 6ꢀꢀ-H), 7.73 (2H, d, J = 9.0 Hz,
3ꢀꢀ and 5ꢀꢀ-H), 7.90 (1H, br s, 2ꢀ-H), 8.62 (1H, d, J = 2 Hz, 7-H), 8.92
(1H, d, J = 2.0 Hz, 5-H), 9.01 (1H, br s, NH), 9.30 (1H, br s, NH) ppm.
13C NMR (75.4 MHz, DMSO-d6): ı 51.6 (OMe), 97.4 (C), 103.4 (C),
117.4 (2ꢀ-CH), 118.1 (2ꢀꢀ and 6ꢀꢀ-CH), 118.7 (CH), 119.3 (C), 121.5
(CH), 129.4 (7-CH), 129.8 (CH), 133.3 (3ꢀꢀ and 5ꢀꢀ-CH), 133.9 (C),
135.0 (C), 137.4 (C), 140.0 (C), 144.1 (C), 145.5 (C), 145.6 (5-CH),
147.9 (C), 152.2 (C O), 164.6 (C O) ppm. HRMS (ESI-TOF) Calcd.
for C23H18N5O3S [M+H]+ 444.1125; found 444.1120.
2.1.2.1. Methyl 3-amino-6-[3-(3-phenylureido)phenyl]thieno[3,2-
b]pyridine-2-carboxylate (2a). From compound 1a (80.0 mg,
0.270 mmol) and phenylisocyanate (32.0 mg) compound 2a was
isolated as a yellow solid (100 mg, 90%), m.p. 226–226.5 ◦C. 1H
NMR (400 MHz, DMSO-d6): ı 3.83 (3H, s, OMe), 6.93 (2H, br s,
NH2), 6.95–6.99 (1H, m, ArH), 7.26–7.30 (2H, m, ArH), 7.40–7.52
(5H, m, ArH), 7.91 (1H, broad s, 2ꢀ-H), 8.62 (1H, d, J = 2 Hz, 7-H),
8.75 (1H, br s, NH), 8.82 (1H, br s, NH), 8.93 (1H, d, J = 2 Hz, 5-H)
ppm. 13C NMR (400 MHz, DMSO-d6): ı 51.5 (OMe), 97.4 (C), 117.0
(2ꢀ-CH), 118.3 (2 × CH), 118.4 (CH), 121.0 (CH), 121.9 (CH), 128.8
(2× CH), 129.3 (7-CH), 129.7 (CH), 133.9 (C), 135.1 (C), 137.3 (C),
139.6 (C), 140.5 (C), 145.4 (C), 145.5 (5-CH), 147.9 (C), 152.6 (C O),
164.6 (C O) ppm. HRMS (ESI-TOF) Calcd. for C22H19N4O4S [M+H]+
419.1172; found 419.1188.
2.1.2.4. Methyl 3-amino-6-[2-(3-phenylureido)phenyl]thieno[3,2-
b]pyridine-2-carboxylate (3a). From compound 1b (125 mg,
0.420 mmol) and phenylisocyanate (50.0 mg) compound 3a was
isolated as a yellow solid (120 mg, 75%), m.p. 226–227 ◦C. 1H NMR
(400 MHz, DMSO-d6): ı 3.83 (3H, s, OMe), 6.91–6.95 (m, 1H, ArH),
6.97 (2H, br s, NH2), 7.17–7.25 (3H, m, ArH), 7.35–7.44 (4H, m,
ArH), 7.86 (1H, br s, NH), 8.00 (1H, dd, J = 8.0 and 1.2 Hz, ArH),
8.43 (1H, d, J = 2 Hz, 7-H), 8.65 (1H, d, J = 2 Hz, 5-H), 8.79 (1H, br s,
NH) ppm. 13C NMR (100.6 MHz, DMSO-d6): ı 51.6 (OMe), 97.3 (C),
118.0 (2× CH), 121.8 (CH), 122.6 (CH), 123.5 (CH), 128.8 (2× CH),
128.9 (CH), 129.1 (C), 130.7 (CH), 132.1 (7-CH), 133.7 (C), 133.8
(C), 136.5 (C), 139.6 (C), 145.3 (C), 147.3 (5-CH), 148.0 (C), 152.6
2.1.2.2. Methyl 3-amino-6-{3-[3-(4-methoxyphenyl)ureido]phenyl}
thieno[3,2-b]pyridine-2-carboxylate (2b). From compound 1a
(150 mg, 0.540 mmol) and 4-methoxyphenylisocyanate (80.0 mg)
compound 2b was isolated as a yellow solid (217 mg, 90%), m.p.
243–244 ◦C. 1H NMR (400 MHz, DMSO-d6): ı 3.71 (s, 3H, OMe),